Novo Nordisk A/S - G8, X9 M.Fl.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Denmark
- Registered address
- Novo Nordisk Park 99, Malov, Hovedstaden 2760, Denmark (DNK)
- Operations here
- analysislabelmanufacturepack
- FDA identifiers
- FEI 3003037054 · DUNS 586793291
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIBioresearch Monitoring2026-04-17
- VAIDrug Quality Assurance2022-06-16
- VAIDrug Quality Assurance2021-05-12
- NAIDrug Quality Assurance2018-06-01
- NAIDrug Quality Assurance2016-04-14
- VAIDrug Quality Assurance2014-03-14
- VAIDrug Quality Assurance2011-09-08
Drugs this plant is listed as making
2 distinct drugs across 3 products name this site in their FDA label.
- estradiolNovo Nordisk
- estradiol/norethindrone acetateAmneal Pharmaceuticals NY LLC
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.